We examined the efficacy of a Rho kinase inhibitor, Fasudil, on cognitive impairment induced by chronic cerebral hypoperfusion in rats. Thirty-two male adult Sprague-Dawley rats were randomly divided into three groups; treated (T), control (C), and sham-operated (Sh); severe stenosis of the carotid arteries was modeled in the former two groups. During two weeks, 8.35 mg/kg Fasudil and physiological saline were i.p. applied twice per day in the T and C groups, respectively. The Morris water maze test was performed in each group to detect changes in the cognitive function and to observe pathological shifts in hippocampal morphology in rats after eight weeks. The mean escape latency was distinctly shorter (P < 0.01), and the percentage of swimming distance within the platform quadrant was significantly greater (P < 0.01) in the T group, compared to those in the C group at the corresponding time points. The rate of carotid artery stenosis in rats demonstrated no statistical difference between the T and C groups (P > 0.05). Fasudil injections effectively normalized hippocampal pathomorphology in the T group. Thus, the Rho kinase inhibitor obviously ameliorated cognitive impairment induced by chronic cerebral hypoperfusion in rats.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
H. J. Barnett, “Carotid disease and cognitive dysfunction,” Ann. Intern. Med., 140, 303-304 (2004).
K. Matsumoto and Y. Murakami, “Neuronal damage and decrease of central aeetylcholine level following permanent occlusion of bilateral common carotid arteries in rat,” Brain Res., 673, 290-296 (1995).
V. Demarin, I. Zavoreo, and V. B. Kes, “Carotid artery disease and cognitive impairment,” J. Neurol. Sci., 322, 107-111 (2012).
B. J. Kwon, M. H. Han, H. S. Kang, and C. Jung, “Protection filter-related events in extracranial carotid artery stenting: a single-center experience,” J. Endovascul. Ther., 13, 711-722 (2006).
J. L. Mas, G. Chatellier, B. Beyssen, et al., “EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis,” N. Engl. J. Med., 355, 1660-1671 (2006).
M. Shibuya, S. Hirai, M. Seto, et al., “Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial,” J. Neurol. Sci., 238, 31-39 (2005).
X. Sun, M. Minohara, H. Kikuchi, et al., “The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis,” J. Neuroimmunol., 180, 126-134 (2006).
L. Huang, Z. He, L. Guo, and H. Wang, “Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of Rho-kinase,” Cell Mol. Neurobiol., 28, 757-768 (2008).
Z. Zhou, Y. Zhang, C. Zhu, et al., “Cognitive functions of carotid artery stenosis in the aged rat,” Neuroscience, 219, 137-144 (2012).
Q. Y. Wu, J. Li, Z. T. Feng, and T. H. Wang, “Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer’s disease rat model,” Neurosci. Lett., 417, 281-285 (2007).
V. C. Hachinski and J.V. Bowler, “Vascular dementia,” Neurologym, 43, 2159-2160 (1993).
L. K. Sztriha, D. Nemeth, T. Sefcsik, and L. Vecsei, “Carotid stenosis and the cognitive function,” J. Neurol. Sci., 283, 36-40 (2009).
Y. Hojo, T. A. Hattori, T. Enami, et al., “Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017 alpha and P450 aromatase localized in neurons,” Proc. Natl. Acad. Sci. USA, 101, 865-870 (2004).
B. K. Mueller, H. Mack, and N. Teusch, “Rho kinase, a promising drug target for neurological disorders,” Nat. Rev. Drug Discov., 4, 387-398 (2005).
Y. Yagita, K. Kitagawa, and T. Sasaki, “Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia,” J. Neurosci. Res., 85, 2460-2469 (2007).
R. M. Pluta, “Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment,” Pharmacol. Ther., 105, 23-56 (2005).
S. Chrissobolis and C. G. Sobey, “Recent evidence for an involvement of Rho-kinase in cerebral vascular disease,” Stroke, 37, 2174-2180 (2006).
Y. Rikitake, H. H. Kim, Z. Huang, et al., “Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection,” Stroke, 36, 2251-2257 (2005).
M. J. Koelemay, P. J. Nederkoorn, J. B. Reitsma, and C. B. Majoie, “Systematic review of computed tomographic angiography for assessment of carotid artery disease,” Stroke, 35, 2306-2312 (2004).
Y. Hirooka and H. Shimokawa, “Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases,” Am. J. Cardiovascul. Drugs, 5, 31-39 (2005).
Y. Matsumoto, T. Uwatoku, K. Oi, et al., “Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of mutiple mechanisms,” Arterioscler. Thromb. Vascul. Biol., 24, 181-186 (2004).
S. Satoh, Y. Toshima, I. Ikegaki, et al., “Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils,” Brain Res., 1128, 175-180 (2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Q., Zhang, JJ. & Han, ZM. Effect of a Rho Kinase Inhibitor on Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. Neurophysiology 47, 402–407 (2015). https://doi.org/10.1007/s11062-016-9548-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-016-9548-z